login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
PASITHEA THERAPEUTICS CORP (KTTA) Stock News
USA
-
Nasdaq
- NASDAQ:KTTA -
US70261F2020
-
Common Stock
1.13
USD
+0.01 (+0.89%)
Last: 12/12/2025, 8:00:02 PM
1.1
USD
-0.03 (-2.65%)
After Hours:
12/12/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
KTTA Latest News, Press Relases and Analysis
All
Press Releases
12 days ago - By: Chartmill
- Mentions:
IRBT
PRPH
CLSD
MDB
...
What's going on in today's after hours session
12 days ago - By: Chartmill
- Mentions:
LEG
GAME
STRO
NFE
...
Top movers in Monday's pre-market session
11 days ago - By: Pasithea
Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock
15 days ago - By: Chartmill
- Mentions:
BEAT
CLSD
YCBD
ADTX
...
Curious about the stocks that are showing activity after the closing bell on Friday?
15 days ago - By: Chartmill
- Mentions:
BEAT
RUBI
CMCT
CLSD
...
Top stock movements in today's session.
15 days ago - By: Chartmill
- Mentions:
HBI
BEAT
INTC
NVDA
...
Friday's session: most active stocks
15 days ago - By: Chartmill
- Mentions:
PW
BEAT
CLSD
KALA
...
Unusual volume stocks are being observed in Friday's session.
15 days ago - By: Chartmill
- Mentions:
PW
DDC
RUBI
CLSD
...
Which stocks are moving on Friday?
15 days ago - By: Stocktwits
- Mentions:
PSIL
VXF
Why Did KTTA Stock Soar A Whopping 48% Today?
15 days ago - By: Pasithea
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
16 days ago - By: Chartmill
- Mentions:
BEAT
OMEX
TLRY
PLAG
...
Top movers in Thursday's after hours session
17 days ago - By: Stocktwits
Pasithea Therapeutics Stock Rockets To Best Day In 4 Years On Massive Share Offering Amid ALS Drug Momentum
17 days ago - By: Chartmill
- Mentions:
DGLY
AMBR
MBRX
OSS
...
Wednesday's session: top gainers and losers
17 days ago - By: Chartmill
- Mentions:
PLUG
NVDA
OPEN
AMBR
...
Curious about the most active stocks on Wednesday?
17 days ago - By: Chartmill
- Mentions:
DGLY
CLSD
ZYXI
GP
...
In today's session, these stocks are experiencing unusual volume.
17 days ago - By: Chartmill
- Mentions:
DGLY
SUPX
AMBR
MBRX
...
Which stocks are moving on Wednesday?
17 days ago - By: Benzinga
Why Pasithea Therapeutics (KTTA) Stock Is Suddenly On Fire Today
18 days ago - By: Chartmill
- Mentions:
ICON
BEAT
CLSD
GP
...
Unusual volume stocks in Tuesday's session
19 days ago - By: Chartmill
- Mentions:
ICON
KEYS
JAGX
PLAG
...
Get insights into the top gainers and losers of Monday's after-hours session.
19 days ago - By: Chartmill
- Mentions:
MVO
EXAS
BEAT
FAT
...
Unusual volume stocks are being observed in Monday's session.
22 days ago - By: Pasithea
Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients
23 days ago - By: Benzinga
- Mentions:
PACS
GNTA
SCYX
NCNA
...
12 Health Care Stocks Moving In Thursday's After-Market Session
23 days ago - By: Pasithea
Pasithea Therapeutics Announces Positive Phase 1 Data Including Partial Response, Demonstrating Monotherapy Clinical Activity and Favorable Safety Profile for PAS-004 in Advanced Cancer Study
a month ago - By: Pasithea
Pasithea Therapeutics Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
3 months ago - By: Pasithea
Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
3 months ago - By: Pasithea
Pasithea Therapeutics Announces Enrollment of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for its Ongoing Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients
4 months ago - By: Pasithea
Pasithea Therapeutics Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
4 months ago - By: Pasithea
Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
5 months ago - By: Pasithea
Pasithea Therapeutics Completes Enrollment and Initial Dosing of First Cohort from its Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients
6 months ago - By: Pasithea
Pasithea Therapeutics Appoints Expert in ETS2-driven Inflammatory Disease to Scientific Advisory Board
6 months ago - By: Pasithea
Pasithea Therapeutics Presents Updated Interim Data from Ongoing Phase 1 Study of PAS-004 at the ASCO Annual Meeting 2025
7 months ago - By: Stocktwits
Pasithea Therapeutics Stock Draws Retail Buzz As Early Data Shows Potential In Treating Inflammatory Diseases
7 months ago - By: Pasithea
Pasithea Therapeutics Announces Preclinical Data that Shows PAS-004 Inhibits ETS2 Signaling, a Key Driver of Inflammation in IBD and Other Large Addressable Market Diseases
Please enable JavaScript to continue using this application.